Morgan Stanley downgraded ResMed (NYSE:RMD) to Equalweight from Overweight and reduced its price target due to concerns over near-term margin expansion and modest earnings growth. The firm projects flat gross margins for fiscal 2027 and lower net profit after tax compared to consensus, factoring in Philips' re-entry into the U.S. device market and the Noctrix acquisition. Despite the downgrade, ResMed's stock is considered undervalued by InvestingPro analysis and maintains a "GREAT" financial health score.

The Kurv Yield Premium Strategy Apple AAPL ETF (AAPY) has declared a monthly dividend of $0.25 per share, payable on June 18, 2026, to shareholders of record on June 17, 2026. While Apple Inc. (AAPL) boasts a strong GF Score of 96/100, indicating potential for long-term returns, concerns are noted regarding its high P/E ratio of 36.18x and significant insider selling amounting to $111.7 million over the past three months. Investors are advised to consider these factors alongside Apple's robust profitability and growth.

Gladstone Capital Management LLP significantly reduced its stake in Philip Morris International (NYSE:PM) by 49.9% in the fourth quarter, selling 406,531 shares and retaining 407,642 shares valued at approximately $65.4 million. Despite this reduction, PM remains Gladstone's 8th largest position, accounting for 6.8% of its portfolio. Philip Morris International recently reported strong quarterly results, exceeding analyst expectations with EPS of $1.96 and revenue of $10.15 billion, and announced a quarterly dividend of $1.47 per share.

Research firm Gartner predicts that half of all AI-related job cuts will be reversed by 2027, highlighting a critical mistake companies are making by replacing roles requiring human judgment with AI. This reversal is largely due to AI's inability to handle nuanced situations, make subjective decisions, or rebuild trust, as demonstrated by Klarna's experience with its AI chatbot. The core lesson is that while AI excels at information retrieval, it cannot replicate human judgment, leading to negative consequences for organizations that fail to understand this distinction.

Citizens has reaffirmed its Market Outperform rating and $12.00 price target for Nexxen (NASDAQ:NEXN) following the company's 2026 Investor Day, noting the stock is undervalued according to InvestingPro analysis. Nexxen increased its 2026 programmatic revenue growth outlook to 13% and its contribution ex-TAC growth forecast to 11%, while maintaining impressive gross profit margins. The positive outlook is supported by Nexxen's integrated technology, differentiated ACR data, expanding CTV inventory, and emerging agentic AI capabilities, with other firms like RBC Capital and Raymond James also raising their price targets after strong Q1 2026 results.

Rakuten Investment Management Inc. significantly increased its stake in Microchip Technology Inc. by over 400% in the fourth quarter, amassing 150,083 shares valued at approximately $9.7 million. This move comes as Microchip Technology reported strong quarterly results, beating EPS and revenue expectations. Analysts generally maintain a "Moderate Buy" rating for the stock, despite recent insider share sales.

Rakuten Investment Management Inc. significantly increased its stake in General Dynamics Corporation by 259.4% in the fourth quarter, acquiring an additional 23,312 shares. This boosted their total holdings to 32,298 shares valued at $10.997 million. Other institutional investors also grew their positions in General Dynamics, while an executive sold a substantial number of shares.

Applied Materials has introduced two new semiconductor manufacturing systems, the Centura Spectra SiN ALD system and the Producer Selectra molybdenum etch system, designed for advanced 3D device architectures. These systems aim to overcome challenges in managing uniform process control within complex 3D structures like GAA transistors, 3D NAND, and 3D DRAM. The technologies address critical needs in materials engineering for scaling semiconductor innovation.

Cboe Global Markets (CBOE) has seen its stock pressured by concerns over competition from prediction market platform Polymarket, leading to a 27.6% drop over the past month. Despite this, Simply Wall St suggests CBOE could be 19.7% undervalued with a fair value of $330.43 per share, based on growth in derivatives, data, and global spot markets. However, the article also notes concentration risk with its S&P index options and potential fee pressure from crypto-linked competition, and points out that the stock currently appears expensive based on an earnings-based P/E ratio compared to its fair ratio.

Veralto Corporation (VLTO) stock has underperformed the Dow Jones Industrials Average (DOWI) and its rival, Federal Signal Corporation (FSS), over the past three months, year-to-date, and over the past 52 weeks. This underperformance is attributed to weaker-than-expected organic growth trends, particularly in its Product Quality & Innovation segment, despite a year-over-year revenue increase in Q1 2026. Analysts, however, maintain a "Moderate Buy" rating with a significant premium target price for VLTO.